Thermo Fisher Scientific
Thermo Fisher Scientific is a globally renowned leader in the scientific solutions and healthcare sectors, operating in over 60 countries and providing one of the most comprehensive portfolios of laboratory instruments, consumables, and testing services. Within the biologics safety testing market, the company offers proven and essential solutions for critical quality control measures. These include gold-standard testing for endotoxins, sterility testing, residual DNA analysis, and the identification of adventitious agents and microbial contamination. Their commitment to innovation is exemplified by products like the QMS™ QSight™ Mass Spectrometer, which enhances the sensitivity and speed for detecting residual host-cell proteins and impurities, and the MycoSEQ™ Mycoplasma Detection Kit, a robust, regulatory-compliant assay. The company has also strategically strengthened its market position by expanding its Good Manufacturing Practices (GMP) lab service offerings with additional mycoplasma and biosafety testing capabilities. Thermo Fisher’s global presence and extensive product range position it as a critical partner for biopharmaceutical and vaccine manufacturers, ensuring the safety, effectiveness, and regulatory compliance of their advanced medicines across all stages of development and large-scale quality assurance.
Latest Market Research Report on Biologics Safety Testing Download PDF Brochure Now
Charles River Laboratories
Charles River Laboratories is a prominent global service and early-stage Contract Research Organization (CRO) that plays a leading role in the biologics safety testing market. Operating through 150 facilities across 21 countries, the company offers exceptional, risk-mitigating testing solutions with deep technical and regulatory expertise. Their comprehensive BioReliance® Contract Testing Services span the entire product life cycle, from early pre-clinical development through to licensed production. Charles River is crucial in characterising the starting materials for biologics, offering extensive Cell and Viral Bank Testing to ensure viral safety and genetic stability. Their core services also cover Lot Release Testing, which readies a biologic for market launch, and the use of new in vivo models for assessing the immunogenicity of biotherapeutics. The company continually advances its offerings, such as the expansion of its endotoxin testing solutions with the launch of the Endosafe® Trillium rCR cartridge. By delivering comprehensive testing and expert regulatory guidance, Charles River is vital in helping clients bring life-changing drugs to market while adhering to strict global safety standards.
Lonza Group
Lonza Group is a major diversified global supplier to the pharmaceutical, biotech, and nutrition markets, and a consistently ranked leader in the biologics safety testing industry. The company is instrumental in advancing biopharmaceutical manufacturing by providing comprehensive contract manufacturing and testing services. Lonza offers critical testing solutions across the biologics development process, supporting the verification of product purity and compliance. A key area of focus is on developing custom, regulatory-compliant solutions for quality control, such as its offerings for endotoxin testing. This includes products like the PYROGENT™ Ultra Gel Clot kits and the innovative PyroTec™ PRO+ Automated Robotic Solution, which increases automation and efficiency for endotoxin testing workflows. Lonza’s strategic collaborations and continuous focus on technological advancements in testing position it as an essential partner for biopharmaceutical companies, helping to ensure the safety and quality of a wide range of biotherapeutics, including novel cell therapy products.
Eurofins Scientific
Eurofins Scientific is a global leader in testing and laboratory services, with its pharmaceutical products testing segment being a significant contributor to the biologics safety testing market. With a vast network of over 800 laboratories across 45 countries, Eurofins offers a comprehensive portfolio of over 200,000 analytical methods. The company’s expertise is pivotal in evaluating the safety, identity, composition, authenticity, origin, and purity of biological substances and products. In the context of biologics safety, Eurofins provides essential services like specialized testing for emerging modalities, including cell and gene therapies. This commitment to innovation led to the accreditation of new testing laboratories and a partnership to develop a novel assay for detecting viral impurities in cell-based therapies. By focusing on high-quality services and accurate results, Eurofins supports the biopharmaceutical industry by ensuring its products meet stringent safety standards and global regulatory requirements, playing a crucial role in the development and quality control of advanced therapeutics.
Merck KGaA (MilliporeSigma)
Merck KGaA, through its life science business MilliporeSigma, is a leading global science and technology company that provides essential products and services across the entire biologics manufacturing workflow, including comprehensive safety testing. Merck offers a broad range of specialized reagents, instruments, and testing services that are crucial for ensuring the safety and quality of biopharmaceuticals. The company’s solutions are used for a variety of tests, including those for endotoxins, bioburden, and residual host contamination. Merck’s expertise supports developers of increasingly complex biologics, such as Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), and mRNA-based vaccines and therapeutics, by providing the necessary analytical capabilities to define and monitor Critical Quality Attributes (CQAs). By delivering specialized, high-quality analytics and product release assays, Merck reinforces its position as a key global supplier that empowers biopharma companies to achieve compliance and accelerate the market readiness of their life-changing drugs.
WuXi AppTec
WuXi AppTec is a global open-access capability and technology platform company that provides a broad range of R&D and manufacturing services to the pharmaceutical, biopharmaceutical, and medical device industries. As a significant player, the company offers comprehensive and integrated biologics safety testing and manufacturing services, which are critical for the development and regulatory approval of biotherapeutics. WuXi AppTec helps clients navigate the complexities of bioprocessing by offering solutions that ensure the quality, safety, and effectiveness of their products. By providing an external, flexible platform, the company enables biopharma firms to outsource essential but time-consuming testing and quality control processes. This strategic outsourcing partnership helps accelerate the overall drug discovery and development timeline, allowing clients to focus on core innovation while WuXi AppTec ensures the safety and quality assurance of the biologics being prepared for clinical trials and commercialization.
Sartorius AG
Sartorius AG is an international pharmaceutical and laboratory equipment supplier that provides comprehensive and compliant biologics testing solutions across all stages of drug development. The company operates global cGMP-compliant testing facilities that are approved by regulatory bodies, including the FDA and MHRA, for the safety testing of viral vector gene therapies, cell therapies, viral vaccines, and both new biologics and biosimilars. Sartorius offers specialized services that are integral to quality control, such as Cell Line Characterization for mammalian cell banks, Product Characterization to address the challenges of complex biologics, and Biologics Lot Release Testing to ready products for market. By offering immediate access to highly specialized, ready-to-use, or custom assays and complex analytical equipment, Sartorius effectively expands a client’s quality control workbench. This outsourcing capability significantly expedites analytical development and lot release timelines for its biopharma partners.
BIOMÉRIEUX
BIOMÉRIEUX is a global company specializing in in-vitro diagnostics, with a significant presence in the industrial segment by providing solutions for microbiological quality control. In the context of biologics safety testing, BIOMÉRIEUX’s technologies are essential for ensuring the sterility and safety of biopharmaceutical products. The company offers a range of innovative products and services focused on rapid microbiology testing, which is critical for quick and reliable detection of microbial contamination, including bacteria, molds, and yeasts. By providing automated and precise detection systems, BIOMÉRIEUX helps pharmaceutical and biotech companies streamline their quality assurance processes. This focus on rapid, accurate, and automated microbial control ensures compliance with stringent international regulatory requirements and minimizes the risk of product recalls, thereby safeguarding the safety of biotherapeutics and advanced medical treatments.
SGS SA
SGS SA, officially SGS Société Générale de Surveillance SA, is the world’s leading inspection, verification, testing, and certification company. Within the healthcare and pharmaceutical sector, SGS provides a wide range of analytical testing services crucial for biologics safety testing. The company’s expertise ensures that biopharmaceutical products meet the highest standards of quality, safety, and regulatory compliance across all global markets. SGS’s services encompass comprehensive quality control testing and lot release testing, including method development and validation. By leveraging their extensive network of specialized laboratories and technical expertise, SGS assists clients in verifying product purity, strength, and potency. Their role as an independent third-party tester provides clients with the assurance needed to bring their biologics and advanced therapies to market safely and efficiently, underscoring their importance as a trusted partner in the biopharma supply chain.
Laboratory Corporation of America Holdings (Labcorp)
Laboratory Corporation of America Holdings, commonly known as Labcorp, is a global life sciences company that provides a comprehensive range of services, including lab testing, research, and product and manufacturing testing. Through strategic acquisitions and its subsidiaries, such as the testing firm Toxikon, Labcorp holds a strong position in the biologics safety testing market. The company offers extensive analytical testing services that are vital for ensuring the safety and quality of biopharmaceuticals, vaccines, and advanced medicines. Labcorp is actively involved in testing services for novel modalities like mRNA-based vaccines and therapeutics and supports gene therapy programs through collaborations that provide access to drug development and manufacturing capabilities. By offering scientific expertise and a full suite of testing from early-stage development to commercialization, Labcorp is a key partner for biopharma organizations seeking to deliver safe and efficacious therapeutic products to patients globally.
Latest Market Research Report on Biologics Safety Testing Download PDF Brochure Now